Lupus low disease activity state attainment in the phase 3 TULIP trials of anifrolumab in active systemic lupus erythematosus

OBJECTIVES: In patients with systemic lupus erythematosus (SLE), lupus low disease activity state (LLDAS) attainment is associated with improved outcomes. We investigated LLDAS attainment in anifrolumab-treated patients. METHODS: We performed post hoc analysis of pooled Treatment of Uncontrolled Lup...

Descripción completa

Detalles Bibliográficos
Autores principales: Morand, Eric F, Abreu, Gabriel, Furie, Richard A, Golder, Vera, Tummala, Raj
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Systemic Lupus Erythematosus
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10176410/
https://www.ncbi.nlm.nih.gov/pubmed/36690388
http://dx.doi.org/10.1136/ard-2022-222748

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10176410/
https://www.ncbi.nlm.nih.gov/pubmed/36690388
http://dx.doi.org/10.1136/ard-2022-222748

Ejemplares similares